Future of Cardiovascular Drug Development - Pharmaceutical Business Review

More White Papers

Published 18 November 2009 | By Centre for Human Drug Research

An uncertain future? It may be a difficult time for cardiovascular drug development, but there are still reasons to be positive, say Koos Burggraaf and Matthijs Moerland at the Centre for Human Drug Research.

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.

Fill In Details

Title* First Name* Last Name* Email* Confirm Email* Telephone* Reason for Download*

Job Title* Job Function* If other job function please specify Company* Country* Company Activity If other company activity please specify

Help us to better improve our communications by entering all or some of the additional fields below, then click 'Download White Paper' to be taken to the next page.

AddressLine1 AddressLine2 City County/State Zip

Fax Company Turnover Number of Employees Role In Purchasing

Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.

Type both words separated by a space below*

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.

If you would prefer not to hear from carefully selected third party companies uncheck this box

By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory

Related Intelligence and Suppliers

White Papers

Future of Cardiovascular Drug Development Centre for Human Drug Research White Papers

Proof of Pharmacological Principle Centre for Human Drug Research White Papers

Latest Products

The NeuroCart The NeuroCart is an unrivaled translational tool, measuring neuropsychological and neurophysiological functions of the brain. It is a proprietary test battery quantifying potential effects of new investigational drugs. Products

Centre for Human Drug Research - Early Phase Drug Development The Centre for Human Drug Research (CHDR) performs clinical studies of innovative medicines with the concept where the maximum amount of information is extracted in the earliest clinical phase, using innovative and complex techniques as reflected in our publication output. Suppliers

Production & Manufacturing Fine & Speciality Chemicals Manufacturing Process & Production OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z